Product
Semapimod
Aliases
CNI-1493
2 clinical trials
1 indication
Indication
Crohn's diseaseClinical trial
A Randomized, Double-Blind, Placebo-controlled Study of CNI-1493 for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment vs. PlaceboStatus: Completed, Estimated PCD: 2004-06-01
Clinical trial
Extension Study of CNI-1493 for Treatment of Moderate to Severe Crohn's DiseaseStatus: Completed, Estimated PCD: 2006-06-01